Not recruiting
End stage renal disease+1
Not recruitingStudy Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease
Registered drugNo placebo
Study Comparing Rifampicin, Isoniazid, and Rifapentine Regimens for Treating Latent Tuberculosis in Patients with End-Stage Kidney Disease
Registered drugNo placebo
- Disease:End stage renal diseaseLatent tuberculosis
- Substances:IsoniazidPyridoxine+2
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Isoniazid
